本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Olema Pharmaceuticals, Inc.

5.27
+0.10502.03%
成交量:46.79萬
成交額:242.59萬
市值:3.60億
市盈率:-2.39
高:5.29
開:5.13
低:5.06
收:5.16
資料載入中...
2024/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/22

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/11

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

SEC問詢函

Form CORRESP - Correspondence
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities